A detailed history of National Bank Of Canada transactions in Ocugen, Inc. stock. As of the latest transaction made, National Bank Of Canada holds 11 shares of OCGN stock, worth $10. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11
Previous 11 -0.0%
Holding current value
$10
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$0.98 - $1.95 $10 - $21
11 New
11 $0
Q4 2023

Feb 06, 2024

BUY
$0.36 - $0.57 $110 - $174
307 Added 102.33%
607 $0
Q3 2022

Oct 13, 2022

SELL
$1.75 - $3.1 $166,425 - $294,810
-95,100 Reduced 99.69%
300 $1,000
Q2 2022

Jul 28, 2022

BUY
$1.83 - $3.45 $111,630 - $210,450
61,000 Added 177.33%
95,400 $217,000
Q1 2022

May 05, 2022

SELL
$2.34 - $4.72 $195,390 - $394,120
-83,500 Reduced 70.82%
34,400 $114,000
Q4 2021

Jan 24, 2022

BUY
$4.38 - $15.67 $516,402 - $1.85 Million
117,900 New
117,900 $536,000

Others Institutions Holding OCGN

About Ocugen, Inc.


  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $199M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.